Specialties
Reports that name this provider
- Chemotherapy & Immunotherapy Quality in Colombia
- Houses Colombia's first in-situ comprehensive genomic profiling program (March 2023 – June 2024). Uses NextSeq2000 platform with TruSight Oncology 500 assay covering 523 genes.
- Medical Technology in Colombia
- Implemented first in-situ comprehensive genomic profiling in Colombia (March 2023-June 2024); NextSeq2000 platform with TruSight Oncology 500 assay analyzing 523 genes